To compare safety and efficacy of very short (≤3 months), short (6 months), standard (12 months) and extended (>12 months) DAPT, and subsequent monotherapies, after DES.
Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug eluting stent implantation: a network Meta-analysis
Benenati, Stefano;De Marzo, Vincenzo;Vergallo, Rocco;Canepa, Marco;Ameri, Pietro;Porto, Italo
2020-01-01
Abstract
To compare safety and efficacy of very short (≤3 months), short (6 months), standard (12 months) and extended (>12 months) DAPT, and subsequent monotherapies, after DES.
File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Benenati-2020-Duration-of-dual-antiplatelet-thera.pdf
accesso chiuso
Descrizione: online Published: 02 November 2020 - Stefano Benenati, Gabriele Crimi, Claudia Canale, Fabio Pescetelli, Vincenzo De Marzo, Rocco Vergallo, Mattia Galli, Roberta Della Bona, Marco Canepa, Pietro Ameri, Filippo Crea, Italo Porto, Duration of dual antiplatelet therapy and subsequent monotherapy type in patients undergoing drug-eluting stent implantation: a network meta-analysis, European Heart Journal - Cardiovascular Pharmacotherapy, Volume 8, Issue 1, January 2022, Pages 56–64, https://doi.org/10.1093/ehjcvp/pvaa127
Tipologia:
Documento in versione editoriale
Dimensione
777.89 kB
Formato
Adobe PDF
|
777.89 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
